IDT Biologika's new Euro 3.5m packaging line for sterile liquid dosage forms has come on stream. The highly automated facility, which can package up to 30 million syringes a year, offers a more efficient option for injectable packaging with fewer manual steps and better quality control. The line took 14 months to complete.
Dr Ralf Pfirmann, ceo of IDT Biologika, said the packaging line offers a higher level of quality control in the filling and packaging of injectables and on medium- to large-sized projects.
"The start-up of this new packaging line represents an important step for IDT Biologika because it brings the same level of efficiency and technology to our packaging operation that we already have in our filling lines for high-value drugs," he added.
IDT Biologika has invested more than Euro 200m in its facilities in Dessau-Roßlau, Germany in the last 15 years, with further investments planned for 2009.
"Our total focus on sterile liquid dosage forms means we have the systems and the expert personnel in a broad range of disciplines required for high-value drugs. We have the ability to take on highly complex projects and to deliver complete solutions for our customers with the highest level of quality control," Pfirmann added.
IDT Biologika is a member of the German Klocke Group. It employs more than 1,300 people at six locations worldwide.